Clinical Trial Update: Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban [Phase 4]

View source ↗

Summary

A phase 4 trial comparing enoxaparin to rivaroxaban for preventing deep vein thrombosis is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Venous Thromboembolism

Drugs mentioned

• Enoxaparin (enoxaparin sodium)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Florida Orthopaedic Institute | Conditions: Deep Vein Thrombosis, Venous Thromboembolism | Phase 4 | Status: UNKNOWN